Elias Zerhouni and Andy Plump discuss the future of multispecific biologics

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/89/45/15/894515df-8cf9-1503-7f86-69eb52e6baea/mza_1769051247888600121.jpg/600x600bb.jpg

The Studio at Kendall Square

BiotechTV

20 episodes

1 week ago

The Studio at Kendall Square is a video podcast studio built by BiotechTV and MassBio at MassBio's headquarters in Tech Square at Kendall Square. It is a platform for the Boston biotech community to use and have your podcast discussions recorded in-person and then broadcast on BiotechTV. The studio will give voice to the vast network of experts who live in and around 'The Most Innovative Square Mile on the Planet'.

Life Sciences

Science

RSS

All content for The Studio at Kendall Square is the property of BiotechTV and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/43071135/43071135-1744021928722-f31a5adf3445.jpg

Elias Zerhouni and Andy Plump discuss the future of multispecific biologics

The Studio at Kendall Square

35 minutes 49 seconds

7 months ago

Elias Zerhouni and Andy Plump discuss the future of multispecific biologics

Interviewed by Andy Plump, President of R&D at Takeda, Dr. Zerhouni discusses the rationale for multispecifics and the science behind them. They also discuss the differences between pharma and biotech, keys to being an effective R&D leader, and advice for both young and experienced people in their careers.